Molecular targeted therapies are revolutionized therapeutics which interfere with specific
molecules to block cancer growth, progression, and metastasis. Many molecular targeted …

Immune checkpoint inhibitors (ICIs) have demonstrated significant clinical impact in
improving overall survival of several malignancies associated with poor outcomes; however …

HIV-1 immunotherapy with a combination of first generation monoclonal antibodies was
largely ineffective in pre-clinical and clinical settings and was therefore abandoned …

Extracellular vesicles (EVs) are increasingly being recognized as candidate drug delivery
systems due to their ability to functionally transfer biological cargo between cells. However …

Purpose To characterize the effect of concurrent stereotactic radiosurgery–stereotactic
radiation therapy (SRS-SRT) and immune checkpoint inhibitors on patient outcomes and …

Herbal remedies were the first medicines used by humans due to the many
pharmacologically active secondary metabolites produced by plants. Some of these …

Nowadays, in cancer treatments, immunotherapy which can be classified as a cancer type
specific therapy is more popular than non-specific therapy methods such as surgery …

Advancements in human genomics over the last two decades have shown that cancer is
mediated by somatic aberration in the host genome. This discovery has incited enthusiasm …

Cancer and autoimmune disease are closely related, and many therapeutic antibodies are
widely used in clinics for the treatment of both diseases. Among them, the anti-CD20 …

The benefits of polyclonal antibodies as tools for assay-specific target discovery and
detection are numerous. As the future of basic research, diagnostics and biomarker …